RELATION OF PLASMA RENIN ACTIVITY TO THE ANTIHYPERTENSIVE EFFECT OF MK 421 IN THE RAT
Open Access
- 1 May 1982
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 76 (1) , 163-168
- https://doi.org/10.1111/j.1476-5381.1982.tb09202.x
Abstract
The effect of the angiotensin converting enzyme inhibitor, MK 421 (N‐((S)‐1‐(ethoxycarbonyl)‐3‐phenylpropyl)‐l‐Ala‐l‐Pro), on the blood pressure of two‐kidney Goldblatt hypertensive rats has been investigated in relation to the initial plasma renin activity (PRA) and the initial blood pressure of the individual animals. Blood pressure was monitored by an indirect tail‐cuff method at 1, 3, 6 and 24 h after dosing. MK 421 produced a fall in blood pressure in the majority of animals, but the extent of this reduction varied considerably between individuals. The change in blood pressure showed a significant correlation with both the initial PRA and the initial blood pressures of the animals. However, only a modest correlation was found between the initial PRA and the degree of hypertension. MK 421 (10 mg/kg, orally) produced a mean blood pressure change which was statistically significant (P< 0.001) at all times tested. It is concluded that the degree of antihypertensive activity of MK 421 is related to the degree of activity of the renin‐angiotensin system which, in this model at least, is reflected by the PRA.Keywords
This publication has 15 references indexed in Scilit:
- Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.BMJ, 1979
- Antihypertensive Effect of Prolonged Blockade of Angiotensin Formation in Benign and Malignant, one- and two-Kidney Goldblatt Hypertensive RatsClinical Science, 1979
- Arterial Wall or Plasma Renin in Hypertension?Clinical Science, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Pathogenesis of malignant hypertension: experimental evidence from the renal hypertensive rat.1975
- Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.Circulation Research, 1975
- Measurement of blood pressure in unanaesthetized rats and mice.1968